-

SHAREHOLDER ALERT: Robbins LLP Announces That The Boston Beer Company, Inc. (SAM) is Being Sued for Misleading Shareholders

SAN DIEGO--(BUSINESS WIRE)--Shareholder rights law firm Robbins LLP announces that a shareholder filed a class action on behalf of all persons and entities that purchased or otherwise acquired The Boston Beer Company, Inc. (NYSE: SAM) securities between April 22, 2021 and September 8, 2021 for violations of the Securities Exchange Act of 1934. Boston Beer is a high-end alcoholic beverage company.

If you suffered a loss due to Boston Beer Company, Inc.'s misconduct, click here.

The Boston Beer Company, Inc. (SAM) Failed to Disclose Deteriorating Sales, Inventory Write-offs, and Shortfall Fees

According to the complaint, on April 22, 2021, Boston Beer announced first quarter 2021 financial results. In so doing, the Company estimated earnings per share between $22.00 and $26.00, an increase from its previously communicated range of between $20.00 and $24.00.

On July 22, 2021, Boston Beer reduced its full year 2021 guidance, citing softer-than-expected sales in the hard seltzer category and overall beer industry and stating that it had "overestimated the growth of the hard seltzer category in the second quarter." Specifically, the Company estimated earnings per share between $18.00 and $22.00, a decrease from the previously reported estimate of between $22.00 and $26.00. When news of this came out, the stock fell 26% on July 23, 2021. Then, on September 8, 2021, the Company withdrew its 2021 financial guidance, citing decelerating sales of hard seltzer products and that it "expects to incur hard seltzer-related inventory write-offs, shortfall fees payable to 3rd party brewers, and other costs" for the remainder of fiscal 2021. The stock fell again on this news.

Throughout the class period, defendants failed to disclose to investors that: (i) Boston Beer's hard seltzer sales were deteriorating; (ii) as a result, Boston Beer was reasonably likely to incur inventory write-offs and shortfall fees payable to third party brewers; and (iii) therefore, Boston Beer's financial results would be adversely impacted.

If you purchased shares of The Boston Beer Company Inc. (SAM) between April 22, 2021 and September 8, 2021, you have until November 15, 2021, to ask the court to appoint you lead plaintiff for the class.

All representation is on a contingency fee basis. Shareholders pay no fees or expenses.

Contact us to learn more:

Aaron Dumas
(800) 350-6003
adumas@robbinsllp.com
Shareholder Information Form

About Robbins LLP: A recognized leader in shareholder rights litigation, the attorneys and staff of Robbins LLP have been dedicated to helping shareholders recover losses, improve corporate governance structures, and hold company executives accountable for their wrongdoing since 2002. To be notified if a class action against The Boston Beer Company, Inc. settles or to receive free alerts when corporate executives engage in wrongdoing, sign up for Stock Watch today.

Attorney Advertising. Past results do not guarantee a similar outcome.

Contacts

Aaron Dumas
Robbins LLP
5040 Shoreham Place
San Diego, CA 92122
adumas@robbinsllp.com
(800) 350-6003
www.robbinsllp.com

More News From Robbins LLP

Investor Notice: Shareholder Rights Law Firm Robbins LLP Informs Investors of the uniQure N.V. Securities Class Action Lawsuit

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP informs stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired uniQure N.V. (NASDAQ: QURE) ordinary shares between September 24, 2025 and October 31, 2025. uniQure is a biotechnology company developing gene therapies for rare diseases. For more information, submit a form, email attorney Aaron Dumas, Jr., or give us a call at (800) 350-6003. The Allegations: Robbins LLP is Investigating Allegations that un...

Investor Notice: Shareholder Rights Law Firm Robbins LLP Informs Investors of the POMDoctor Ltd. Securities Class Action Lawsuit

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP informs stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired POMDoctor, Ltd. (NASDAQ: POM) securities between October 9, 2025 and December 11, 2025. POMDoctor claims to be "a leading online medical services platform for chronic diseases in China." For more information, submit a form, email attorney Aaron Dumas, Jr., or give us a call at (800) 350-6003. The Allegations: Robbins LLP is Investigating Alleg...

Investor Notice: Shareholder Rights Law Firm Robbins LLP Informs Investors of the Inovio Pharmaceuticals, Inc. Class Action Lawsuit

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP informs stockholders that a class action was filed on behalf of all persons that purchased or otherwise acquired Inovio Pharmaceuticals, Inc. (NASDAQ: INO) securities between October 10, 2023 and December 26, 2025. Inovio is a biotechnology company focused on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with, inter alia, human papillomavirus (“HPV”). For more information, submit a...
Back to Newsroom